The global iron deficiency anemia therapy market size was worth around USD 5.08 billion in 2024 and is predicted to grow to around USD 10.26 billion by 2035 with a compound annual growth rate (CAGR) of 6.6% from 2025 to 2035. The growth of the iron deficiency anemia therapy market is driven by increasing anemia prevalence, advancements in iron formulations, rising awareness of nutritional health, government initiatives to reduce anemia, and growing adoption of effective intravenous iron therapies across healthcare systems worldwide.